Karin Peterson - Clinical Laserthermia Chief Officer

CLS-B Stock

SEK 4.20 0.16 3.67%

Insider

Karin Peterson is Chief Officer of Clinical Laserthermia Systems

Phone	46 46 15 21 00
Web	https://www.clinicallaser.se

Clinical Laserthermia Management Efficiency

The company has return on total asset (ROA) of (0.6625) % which means that it has lost $0.6625 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5892) %, meaning that it generated substantial loss on money invested by shareholders. Clinical Laserthermia's management efficiency ratios could be used to measure how well Clinical Laserthermia manages its routine affairs as well as how well it operates its assets and liabilities.

Compare Clinical Laserthermia to Peers

Predict price of Clinical Laserthermia

Clinical Laserthermia Systems has accumulated 100 K in total debt with debt to equity ratio (D/E) of 3.2, implying the company greatly relies on financing operations through barrowing. Clinical Laserthermia has a current ratio of 3.54, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Clinical Laserthermia until it has trouble settling it off, either with new capital or with free cash flow. So, Clinical Laserthermia's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Clinical Laserthermia sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Clinical to invest in growth at high rates of return. When we think about Clinical Laserthermia's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Charlotte Walldal	Xvivo Perfusion AB	56
	Jason Clifton	BICO Group AB	N/A
	Henrik Ljung	SpectraCure AB	65
	Lena BSc	Xvivo Perfusion AB	58
	Karin Danielsson	BICO Group AB	41
	Hector Martinez	BICO Group AB	38
	Andreas MD	Xvivo Perfusion AB	46
	Hanna Wilkman	Stille AB	56
	Niklas Carln	Stille AB	49
	Asa Hillsten	BICO Group AB	48
	Johannes Swartling	SpectraCure AB	51
	Mikael Engblom	BICO Group AB	46
	Jaya Tiwari	Xvivo Perfusion AB	N/A
	Kristoffer Nordstrom	Xvivo Perfusion AB	38
	Johan Holmstrom	Xvivo Perfusion AB	53
	Itedale Redwan	BICO Group AB	N/A
	Lotta Bus	BICO Group AB	53
	Erik Gatenholm	BICO Group AB	34
	Artur Aira	BICO Group AB	56
	John Anderson	Stille AB	48
	Kristina Holst	SpectraCure AB	N/A

Clinical Laserthermia Systems AB develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. Clinical Laserthermia Systems AB has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring and a collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery. Clinical Laserthermia is traded on Stockholm Stock Exchange in Sweden. Clinical Laserthermia Systems (CLS-B) is traded on Stockholm Exchange in Sweden and employs 12 people.

Management Performance

	Return On Equity	-2.59
	Return On Asset	-0.66

Clinical Laserthermia Leadership Team

Elected by the shareholders, the Clinical Laserthermia's board of directors comprises two types of representatives: Clinical Laserthermia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Clinical. The board's role is to monitor Clinical Laserthermia's management team and ensure that shareholders' interests are well served. Clinical Laserthermia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Clinical Laserthermia's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Rolf Bornschein, Chief Officer
	Mats Ekelund, Chief Officer
	LarsErik Eriksson, CoFounder Director
	Stephan MSc, Head Devel
	Karin Peterson, Chief Officer
	Marie MSc, Quality Mang
	Dan Mogren, Chief Officer

Clinical Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Clinical Laserthermia a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-2.59
	Return On Asset	-0.66
	Operating Margin	(23.95) %
	Current Valuation	73.29 M
	Shares Outstanding	134.52 M
	Shares Owned By Insiders	9.70 %
	Shares Owned By Institutions	2.27 %
	Price To Earning	(10.13) X
	Price To Book	4.26 X
	Price To Sales	28.92 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Clinical Stock Analysis

When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC